Ildong Pharmaceutical Co., Ltd. (249420.KS) KSC

Currency In KRW

AD

Valuation

Market Cap1.16T
Enterprise Value1.24T
P/E Ratio10.8
PEG Ratio0.01
Price/Sales Ratio0.83
Price/Book Ratio1.2
Enterprise/Revenue0.98
Enterprise/EBITDA-103.47

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.07
Operating Margin0.04
AD

Management Effectiveness

Return On Assets0.08
Return On Equity0.18

Income Statement

Revenue566.93B
Revenue/Share28,721.8
Gross Profit214.76B
EBITDA39.9B
Net Income27.66B
Diluted EPS936.77

Balance Sheet

Total Cash60.37B
Total Cash/Share2,977.4
Total Debt142.05B
Total Debt/Equity0.55
Current Ratio1
Book Value Per Share12,308.29

Price History

52-Week Change-32.66
52-Week High45,050
52-Week Low11,250
Moving Average 50 Days14,732.8
Moving Average 200 Days26,348.25

Statistics

Average Volume265,853
Shares Outstanding31.51M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate200
Trailing Annual Dividend Yield1.31
Payout Ratio0.14
Last Split Factor21:20
Last Split DateMarch 05, 2020
AD